InvestorsHub Logo
Followers 209
Posts 32080
Boards Moderated 1
Alias Born 06/30/2009

Re: None

Tuesday, 02/28/2017 8:14:09 AM

Tuesday, February 28, 2017 8:14:09 AM

Post# of 146194
Why hasn't Boniuk filed his share acquisitions?

"On February 8, 2017, NanoViricides, Inc. (the “Company”) entered into agreements with certain holders (the “Holders”) of the Company’s Series B Convertible Debentures (the “Debentures”), namely, an entity controlled by Board member Dr. Milton Boniuk and the Boniuk Charitable Foundation. The Company and the Holders agreed to convert an aggregate of $5,000,000 of principal and accrued interest of $27,178 of the Debentures, which was payable on January 31, 2017 (the “Maturity Date”) into 4,359,656 newly-issued, restricted shares (the “Conversion Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”)."

He filed a Form 4 prior to the referenced conversion disavowing his beneficial ownership of any Charitable Foundation holdings but what about the other $3,000,000 worth of shares?

The filing is almost 3 weeks overdue and if and when he files it it will answer a NEW question. The 8-K quote above was the first time that it was reported that $3M worth of the debenture was owned by "an entity controlled by Board member Dr. Milton Boniuk". The non-Foundation $4M of holdings were reported as being held by Boniuk Interests, Ltd ($2M), Vivien Boniuk ($1M),
Robert Gold ($.5M) and David Gold ($.5M).

It appears that Boniuk Interests, Ltd or some other entity controlled by Board member Dr. Milton Boniuk acquired the holdings of his sister OR the Gold's.

This should be good if he ever gets around to fulfilling his filing obligations.







I was given that information....I don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News